These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 18052569)

  • 1. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update.
    Moore TA; Buchanan RW; Buckley PF; Chiles JA; Conley RR; Crismon ML; Essock SM; Finnerty M; Marder SR; Miller DD; McEvoy JP; Robinson DG; Schooler NR; Shon SP; Stroup TS; Miller AL
    J Clin Psychiatry; 2007 Nov; 68(11):1751-62. PubMed ID: 18052569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update.
    Miller A; Hall CS; Buchanan RW; Buckley PF; Chiles JA; Conley RR; Crismon ML; Ereshefsky L; Essock SM; Finnerty M; Marder SR; Miller DD; McEvoy JP; Rush AJ; Saeed SA; Schooler NR; Shon SP; Stroup S; Tarin-Godoy B
    J Clin Psychiatry; 2004 Apr; 65(4):500-8. PubMed ID: 15119912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder.
    Suppes T; Dennehy EB; Hirschfeld RM; Altshuler LL; Bowden CL; Calabrese JR; Crismon ML; Ketter TA; Sachs GS; Swann AC;
    J Clin Psychiatry; 2005 Jul; 66(7):870-86. PubMed ID: 16013903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Texas Medication Algorithm Project: development and implementation of the schizophrenia algorithm.
    Chiles JA; Miller AL; Crismon ML; Rush AJ; Krasnoff AS; Shon SS
    Psychiatr Serv; 1999 Jan; 50(1):69-74. PubMed ID: 9890582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical health monitoring of patients with schizophrenia.
    Marder SR; Essock SM; Miller AL; Buchanan RW; Casey DE; Davis JM; Kane JM; Lieberman JA; Schooler NR; Covell N; Stroup S; Weissman EM; Wirshing DA; Hall CS; Pogach L; Pi-Sunyer X; Bigger JT; Friedman A; Kleinberg D; Yevich SJ; Davis B; Shon S
    Am J Psychiatry; 2004 Aug; 161(8):1334-49. PubMed ID: 15285957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early use of clozapine for poorly responding first-episode psychosis.
    Agid O; Remington G; Kapur S; Arenovich T; Zipursky RB
    J Clin Psychopharmacol; 2007 Aug; 27(4):369-73. PubMed ID: 17632221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are second generation antipsychotics a distinct class?
    Bonham C; Abbott C
    J Psychiatr Pract; 2008 Jul; 14(4):225-31. PubMed ID: 18664891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight.
    Freudenreich O; Cather C; Evins AE; Henderson DC; Goff DC
    J Clin Psychiatry; 2004 Oct; 65(10):1372-6. PubMed ID: 15491241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Leponex, 10 years after -- a clinical review].
    Llorca PM; Pere JJ
    Encephale; 2004; 30(5):474-91. PubMed ID: 15627052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects.
    Conley RR; Kelly DL
    Isr J Psychiatry Relat Sci; 2005; 42(1):51-60. PubMed ID: 16134407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia.
    Kumra S; Oberstar JV; Sikich L; Findling RL; McClellan JM; Vinogradov S; Charles Schulz S
    Schizophr Bull; 2008 Jan; 34(1):60-71. PubMed ID: 17923452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments (SMART-CAT) in first-episode schizophrenia patients: Rationale and trial design.
    Li X; Guo X; Fan X; Feng T; Wang C; Yao Z; Xu X; Chen Z; Wang H; Xie S; He J; Zhuo K; Xiang Q; Cen H; Wang J; Smith RC; Jin H; Keshavan MS; Marder SR; Davis JM; Jiang K; Xu Y; Liu D
    Schizophr Res; 2021 Apr; 230():87-94. PubMed ID: 33279374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine Combination and Augmentation Strategies in Patients With Schizophrenia -Recommendations From an International Expert Survey Among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group.
    Wagner E; Kane JM; Correll CU; Howes O; Siskind D; Honer WG; Lee J; Falkai P; Schneider-Axmann T; Hasan A;
    Schizophr Bull; 2020 Dec; 46(6):1459-1470. PubMed ID: 32421188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder.
    Crismon ML; Trivedi M; Pigott TA; Rush AJ; Hirschfeld RM; Kahn DA; DeBattista C; Nelson JC; Nierenberg AA; Sackeim HA; Thase ME
    J Clin Psychiatry; 1999 Mar; 60(3):142-56. PubMed ID: 10192589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis.
    Smith RC; Leucht S; Davis JM
    Psychopharmacology (Berl); 2019 Feb; 236(2):545-559. PubMed ID: 30506237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response.
    Breier AF; Malhotra AK; Su TP; Pinals DA; Elman I; Adler CM; Lafargue RT; Clifton A; Pickar D
    Am J Psychiatry; 1999 Feb; 156(2):294-8. PubMed ID: 9989566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.